Two 59%+ winners, four above 25% in Aug – How this AI model keeps picking winners
Hyong Kim, Chief Medical Officer of Alignment Healthcare, Inc. (NASDAQ:ALHC), a healthcare company with a market capitalization of $2.99 billion, sold 18,600 shares of common stock on August 13, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The shares were sold at a weighted-average price of $15.0327, resulting in a total transaction value of $279,608.
The prices for the shares sold ranged from $15.00 to $15.09. Following the transaction, Kim directly owns 472,167 shares of Alignment Healthcare.
The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 14, 2025. While currently unprofitable, InvestingPro analysts expect Alignment Healthcare to achieve profitability this year. Get access to 7 more exclusive InvestingPro Tips and comprehensive analysis in the Pro Research Report.
In other recent news, Alignment Healthcare reported impressive second-quarter 2025 earnings, significantly surpassing analysts’ expectations. The company achieved an earnings per share (EPS) of $0.07, far exceeding the anticipated -$0.07. Revenue also outperformed forecasts, reaching $1 billion compared to the expected $960.51 million. This robust performance was accompanied by a 6% increase in revenue forecasts and a $32 million higher than anticipated EBITDA for core operations. Membership growth also slightly exceeded projections by 1%. In light of these results, Barclays upgraded Alignment Healthcare’s stock rating from Underweight to Equalweight and raised its price target from $9.00 to $13.00. These developments underscore a period of strong business growth for Alignment Healthcare.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.